Zuber, K. (XXXX). XXXXXXXXXX of diabetes in XXXXXXXX with end-stage XXXXXX XXXXXXX: XXXXXXXXXXX XXXXXXX in XXXXXXXX XXXXXXXX XXXX deteriorating kidney function XXXXXXX close monitoring XXX dose adjustments in XXXXX XXXXXXXXXXXXXXXXX XXXXXXXXXXX.XXXXX-XXXXXXX of the American XXXXXXX XX Physicians XXXXXXXXXX,XX(11), XX.